Titolo:  Bioglass and bioceramic composites processed by Spark Plasma Sintering (SPS): biological evaluation Versus SBF test
Data di pubblicazione:  2018
Autori: 
Autori:  Bellucci, D.; Salvatori, R.; Cannio, M.; Luginina, M.; Orrù, R.; Montinaro, S.; Anesi, A.; Chiarini, L.; Cao, G.; Cannillo, V.
Numero degli autori:  10
Lingua:  Inglese
Presenza coautori internazionali:  no
Rivista:  BIOMEDICAL GLASSES
Volume:  4
Fascicolo:  1
Pagina iniziale:  21
Pagina finale:  31
Numero di pagine:  11
Digital Object Identifier (DOI):  http://dx.doi.org/10.1515/bglass-2018-0003
Codice identificativo Scopus:  2-s2.0-85047416285
URL:  https://www.degruyter.com/view/journals/bglass/4/1/article-p21.xml
Abstract:  The biocompatibility of hydroxyapatite (HA), a lab-made bioglass (BGCaMIX) with high crystallization temperature and different HA/BGCaMIX composites, produced by Spark Plasma Sintering (SPS), was tested with respect to murine osteocytes both by direct and indirect tests, in order to also investigate possible cytotoxic effects of the samples’ extracts. Previous investigations demonstrated that the samples’ bioactivity, evaluated in a simulated body fluid solution (SBF), increased with the increasing amount of BGCaMIX in the sample itself. Although none of the samples were cytotoxic, the findings of the biological evaluation did not confirm those arising from the SBF assay. In particular, the results of direct tests did not show an enhanced “biological performance” of materials with higher glass content. This finding may be due to the high release of ions and particulate from the glass phase. On the contrary, the performance of the BGCaMIX alone is better for the indirect tests, based on filtered samples’ extracts. This work further demonstrates that, when considering bioglasses and HA/bioglass composites, the results of the SBF assays should be interpreted with great care, making sure that the results arising from direct contact tests are integrated with those arising fromthe indirect ones.
Parole chiave:  Bioactive glasses; Spark Plasma Sintering; Cytotoxicity Tests
Tipologia: 1.1 Articolo in rivista

File in questo prodotto:
File Descrizione Tipologia Licenza  
Bioglass and bioceramic composites processed by Spark Plasma Sintering (SPS)_new.pdf  Articolo principale versione editoriale Open Access Visualizza/Apri

Questionario e social

Condividi su: